C.T. Development America
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, C.T. Development America sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
C.T. Development America: 3 sponsored US clinical trials, none currently recruiting.
C.T. Development America sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Amyloidosis, with 1 trials.
Upper-quartile sponsor footprint
C.T. Development America sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
A Study of RX-10045 in the Treatment of Dry Eye Disease
NCT01675570
Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis
NCT01639846
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
NCT01215747
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
Therapeutic Areas
How the C.T. Development America early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Amyloidosis (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
C.T. Development America: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
C.T. Development America sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this C.T. Development America page
3 registered trials is a research-attention snapshot, not an endorsement of C.T. Development America or any single study.
- None of C.T. Development America's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Amyloidosis is the condition C.T. Development America studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Amyloidosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. C.T. Development America pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.